Concourse Financial Group Securities, Inc. Senti Biosciences, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding SNTI
# of Institutions
20Shares Held
10.4MCall Options Held
0Put Options Held
0-
Nea Management Company, LLC Timonium, MD4.43MShares$13.1 Million0.12% of portfolio
-
8 Vc Gp I, LLC Austin, TX2.54MShares$7.49 Million8.67% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.59MShares$4.68 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA707KShares$2.09 Million0.0% of portfolio
-
Intel Corp Santa Clara, CA596KShares$1.76 Million0.12% of portfolio
About Senti Biosciences, Inc.
- Ticker SNTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,757,100
- Market Cap $129M
- Description
- Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...